Literature DB >> 12604362

Unusual function of the activation loop in the protein kinase DYRK1A.

Stephan Wiechmann1, Hanna Czajkowska, Katrin de Graaf, Joachim Grötzinger, Hans-Georg Joost, Walter Becker.   

Abstract

Protein kinases of the DYRK (dual-specificity tyrosine phosphorylation-regulated kinase) family require phosphorylation of a conserved tyrosine residue in the activation loop for full activity. Here we have characterized the role of conserved amino acids that are located in the vicinity of the phosphorylated tyrosine in DYRK1A (Tyr-321). Mutation of Gln-323, but not Asn-365 or Glu-366, to either alanine, glutamate, or asparagine reduced the in vitro-kinase activity of DYRK1A towards the peptide substrate, DYRKtide, to a similar degree (15-37% of wild type) as the mutation of the phosphorylation site itself (Y321F). Similarly, the in vivo-kinase activity of DYRK1A-Q323N and of DYRK1A-Y321F, as assessed by Ser-727 phosphorylation of signal transducer and activator of transcription 3 (STAT3) in COS-7 cells, was markedly reduced in comparison with wild type DYRK1A. These data show that the contribution of Gln-323 and Tyr-321 to the full catalytic activity of DYRK1A is a specific functional characteristic of the DYRK family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604362     DOI: 10.1016/s0006-291x(03)00148-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling.

Authors:  Barbara Hämmerle; Edgar Ulin; Jordi Guimera; Walter Becker; François Guillemot; Francisco J Tejedor
Journal:  Development       Date:  2011-06       Impact factor: 6.868

2.  Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.

Authors:  Lucas M Bronicki; Claire Redin; Severine Drunat; Amélie Piton; Michael Lyons; Sandrine Passemard; Clarisse Baumann; Laurence Faivre; Julien Thevenon; Jean-Baptiste Rivière; Bertrand Isidor; Grace Gan; Christine Francannet; Marjolaine Willems; Murat Gunel; Julie R Jones; Joseph G Gleeson; Jean-Louis Mandel; Roger E Stevenson; Michael J Friez; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2015-04-29       Impact factor: 4.246

3.  DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

Authors:  Jianling Ji; Hane Lee; Bob Argiropoulos; Naghmeh Dorrani; John Mann; Julian A Martinez-Agosto; Natalia Gomez-Ospina; Natalie Gallant; Jonathan A Bernstein; Louanne Hudgins; Leah Slattery; Bertrand Isidor; Cédric Le Caignec; Albert David; Ewa Obersztyn; Barbara Wiśniowiecka-Kowalnik; Michelle Fox; Joshua L Deignan; Eric Vilain; Emily Hendricks; Margaret Horton Harr; Sarah E Noon; Jessi R Jackson; Alisha Wilkens; Ghayda Mirzaa; Noriko Salamon; Jeff Abramson; Elaine H Zackai; Ian Krantz; A Micheil Innes; Stanley F Nelson; Wayne W Grody; Fabiola Quintero-Rivera
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

4.  Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactions.

Authors:  Dan Li; Rebecca A Jackson; Permeen Yusoff; Graeme R Guy
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

5.  The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.

Authors:  Christopher Agnew; Lijun Liu; Shu Liu; Wei Xu; Liang You; Wayland Yeung; Natarajan Kannan; David Jablons; Natalia Jura
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

6.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

7.  Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.

Authors:  Natarajan Kannan; Andrew F Neuwald
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

8.  Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.

Authors:  Meera Soundararajan; Annette K Roos; Pavel Savitsky; Panagis Filippakopoulos; Arminja N Kettenbach; Jesper V Olsen; Scott A Gerber; Jeyanthy Eswaran; Stefan Knapp; Jonathan M Elkins
Journal:  Structure       Date:  2013-05-09       Impact factor: 5.006

9.  The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site.

Authors:  Katrin de Graaf; Hanna Czajkowska; Sabine Rottmann; Len C Packman; Richard Lilischkis; Bernhard Lüscher; Walter Becker
Journal:  BMC Biochem       Date:  2006-03-02       Impact factor: 4.059

10.  Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome.

Authors:  Eishi Funakoshi; Takamitsu Hori; Tokuko Haraguchi; Yasushi Hiraoka; Jun Kudoh; Nobuyoshi Shimizu; Fumiaki Ito
Journal:  BMC Cell Biol       Date:  2003-09-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.